Clinical trial NCT06547788: LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY
Official title: LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Mitral Regurgitation
Mitral Valve Disease
Heart Failure
Lead sponsor: Ottawa Heart Institute Research Corporation
Sponsor class: OTHER
First posted: 2024-08-09
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Mitral valve leakage, or mitral regurgitation (MR), is associated with heart failure symptoms including shortness of breath, fatigue, irregular heart rate. When left untreated, it may cause death. Patients with MR can be divided in two broad groups: those with primary MR, caused by disease of the mitral valve structures, and those with secondary MR, due to dilation of the heart chambers. Our study focuses on patients with primary MR.

The standard treatment for severe symptomatic primary MR is mitral valve surgery, a type of open-heart surgery. The outcomes following this procedure are excellent, however, a subset of patients continue to experience heart failure symptoms after surgery due to very high pressures in the heart, more specifically in the left atrium, which is one of the four heart chambers. This is called functional mitral stenosis (FMS).

Previous studies have shown that creating a small opening between the left and right atria can help relieve the pressure inside the left atrium. We would like to determine whether creating this opening between the two atria at the time of mitral valve surgery can help prevent FMS. To answer this question, we will study two groups of patients who need mitral valve surgery for primary MR. The first group will undergo mitral valve surgery, along with the creation of the opening between the two atria. The second group will undergo mitral valve surgery alone. We will then compare the outcomes between both groups, namely with regards to their heart failure symptoms after open-heart surgery.


Eligibility criteria: Inclusion Criteria:

* Patients ≥18 years of age
* Severe (4+) symptomatic Carpentier Type II MR due to degenerative disease
* Planned surgical mitral valve repair
* Right-to-left atrial pressure gradient ≥ 5 mmHg at baseline
* Pulmonary vascular resistance ≤ 4 Wood units

Exclusion Criteria:

* Secondary causes of MR and mixed mitral valve disease
* Infective endocarditis within 30-days
* Any prior mitral valve intervention
* Need for emergency intervention or surgery
* Left ventricular ejection fraction 2+

Primary outcomes:
measure: Feasibility: recruitment rate
timeFrame: 30 Months
measure: Feasibility: Success rate of intervention
timeFrame: 30 Months
measure: Feasibility: Study follow-up rate and length
timeFrame: 30 Months
Secondary outcomes:
Other outcomes:
Locations:
city: Ottawa
country: Canada
facility: University of Ottawa Heart Institute
state: Ontario
Study officials:
affiliation: Ottawa Heart Institute Research Corporation
name: Vincent Chan, Dr.
role: PRINCIPAL_INVESTIGATOR
References: